Personal tools

Coexpression cluster:C202: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C202_salivary_skin_penis_tongue_uterus_cervical_immature |id=C202 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C202_salivary_skin_penis_tongue_uterus_cervical_immature
|full_id=C202_salivary_skin_penis_tongue_uterus_cervical_immature
|gostat_on_coexpression_clusters=GO:0008544!epidermis development!7.04856330701466e-07!3848;3858;353133;353134;353131$GO:0007398!ectoderm development!7.04856330701466e-07!3848;3858;353133;353134;353131$GO:0009888!tissue development!1.85687015891158e-05!3848;3858;353133;353134;353131$GO:0031424!keratinization!4.38422775379148e-05!353133;353134;353131$GO:0009913!epidermal cell differentiation!7.63587513186168e-05!353133;353134;353131$GO:0048730!epidermis morphogenesis!9.04537395326773e-05!353133;353134;353131$GO:0048729!tissue morphogenesis!0.000175394644674861!353133;353134;353131$GO:0048513!organ development!0.000260134436990178!3848;3858;353133;7353;353134;353131$GO:0048731!system development!0.00159417645728387!3848;3858;353133;7353;353134;353131$GO:0005882!intermediate filament!0.00386161842764485!3848;3858;51350$GO:0045111!intermediate filament cytoskeleton!0.00386161842764485!3848;3858;51350$GO:0048856!anatomical structure development!0.00409978112833119!3848;3858;353133;7353;353134;353131$GO:0007275!multicellular organismal development!0.00796701061421971!3848;3858;353133;7353;353134;353131$GO:0035030!phosphoinositide 3-kinase complex, class IA!0.008242081714353!5295$GO:0001867!complement activation, lectin pathway!0.0144204585980542!3848$GO:0043559!insulin binding!0.0144204585980542!5295$GO:0009653!anatomical structure morphogenesis!0.017490948924798!3848;353133;353134;353131$GO:0043125!ErbB-3 class receptor binding!0.025625053188339!5295$GO:0043560!insulin receptor substrate binding!0.0303387592429232!5295$GO:0032502!developmental process!0.037338278254163!3848;3858;353133;7353;353134;353131$GO:0048009!insulin-like growth factor receptor signaling pathway!0.0383951793796147!5295$GO:0005856!cytoskeleton!0.0383951793796147!3848;3858;65059;51350$GO:0042730!fibrinolysis!0.0383951793796147!3848$GO:0017046!peptide hormone binding!0.0383951793796147!5295$GO:0017089!glycolipid transporter activity!0.0383951793796147!51228$GO:0051861!glycolipid binding!0.0383951793796147!51228$GO:0035014!phosphoinositide 3-kinase regulator activity!0.0383951793796147!5295$GO:0046836!glycolipid transport!0.0397103858141704!51228$GO:0030280!structural constituent of epidermis!0.0397103858141704!3858$GO:0005159!insulin-like growth factor receptor binding!0.042216059074444!5295$GO:0030195!negative regulation of blood coagulation!0.0445584391949209!3848$GO:0032501!multicellular organismal process!0.0453360829683806!3848;3858;353133;7353;353134;353131$GO:0030193!regulation of blood coagulation!0.0453360829683806!3848
|id=C202
|id=C202
}}
}}

Revision as of 17:36, 18 May 2012


Full id: C202_salivary_skin_penis_tongue_uterus_cervical_immature



Phase1 CAGE Peaks

Hg19::chr10:134756449..134756462,+p@chr10:134756449..134756462
+
Hg19::chr10:30847379..30847383,-p@chr10:30847379..30847383
-
Hg19::chr10:47740297..47740299,+p1@FAM25HP
Hg19::chr11:34218778..34218792,+p@chr11:34218778..34218792
+
Hg19::chr11:85195171..85195180,+p@chr11:85195171..85195180
+
Hg19::chr11:86285462..86285463,-p@chr11:86285462..86285463
-
Hg19::chr12:110318334..110318354,-p2@GLTP
Hg19::chr12:53070961..53070973,-p@chr12:53070961..53070973
-
Hg19::chr12:53074182..53074197,-p1@KRT1
Hg19::chr12:53171128..53171131,-p1@KRT76
Hg19::chr15:28560796..28560799,+p1@ENST00000544920
Hg19::chr16:70597904..70597915,+p5@SF3B3
Hg19::chr17:38261177..38261211,-p@chr17:38261177..38261211
-
Hg19::chr17:38975796..38975805,-p13@KRT10
Hg19::chr17:38975820..38975830,-p10@KRT10
Hg19::chr17:38975839..38975846,-p14@KRT10
Hg19::chr17:38975850..38975854,-p19@KRT10
Hg19::chr17:38975877..38975899,-p4@KRT10
Hg19::chr17:38975907..38975928,-p3@KRT10
Hg19::chr17:38976407..38976413,-p20@KRT10
Hg19::chr17:38976601..38976615,-p@chr17:38976601..38976615
-
Hg19::chr17:38976637..38976653,-p@chr17:38976637..38976653
-
Hg19::chr17:38976811..38976823,-p@chr17:38976811..38976823
-
Hg19::chr17:38976838..38976861,-p@chr17:38976838..38976861
-
Hg19::chr17:38976882..38976895,-p@chr17:38976882..38976895
-
Hg19::chr17:38976909..38976919,-p@chr17:38976909..38976919
-
Hg19::chr17:38977317..38977333,-p@chr17:38977317..38977333
-
Hg19::chr17:38977346..38977362,-p@chr17:38977346..38977362
-
Hg19::chr17:38977367..38977371,-p@chr17:38977367..38977371
-
Hg19::chr17:38978257..38978272,-p6@KRT10
Hg19::chr17:38978288..38978293,-p21@KRT10
Hg19::chr17:38978422..38978432,-p12@KRT10
Hg19::chr17:38978519..38978529,-p9@KRT10
Hg19::chr17:38978526..38978535,+p@chr17:38978526..38978535
+
Hg19::chr17:38978586..38978620,-p5@KRT10
Hg19::chr17:38978621..38978636,-p8@KRT10
Hg19::chr17:38978676..38978690,-p3@AB590331
Hg19::chr17:38978718..38978740,-p1@AB590331
Hg19::chr17:38978741..38978756,-p2@AB590331
Hg19::chr17:38978856..38978875,-p1@KRT10
Hg19::chr17:995196..995215,-p22@ABR
Hg19::chr18:28742652..28742696,-p1@DSC1
Hg19::chr18:28742704..28742718,-p3@DSC1
Hg19::chr18:28742813..28742824,-p2@DSC1
Hg19::chr19:24006861..24006869,-p@chr19:24006861..24006869
-
Hg19::chr19:35981358..35981374,-p1@KRTDAP
Hg19::chr19:36004543..36004557,-p3@DMKN
Hg19::chr19:39575002..39575011,+p2@PAPL
Hg19::chr19:6333599..6333612,-p1@ACER1
Hg19::chr19:6333614..6333628,-p2@ACER1
Hg19::chr1:152769195..152769200,+p1@LCE1D
Hg19::chr1:152779121..152779133,-p1@LCE1C
Hg19::chr1:152783824..152783828,+p@chr1:152783824..152783828
+
Hg19::chr1:152798501..152798507,+p1@LCE1A
Hg19::chr1:152919679..152919684,+p@chr1:152919679..152919684
+
Hg19::chr1:82165350..82165387,+p7@LPHN2
Hg19::chr20:42647752..42647774,-p@chr20:42647752..42647774
-
Hg19::chr20:43753104..43753107,-p1@WFDC12
Hg19::chr21:45943378..45943388,+p@chr21:45943378..45943388
+
Hg19::chr22:19466467..19466531,-p4@UFD1L
Hg19::chr2:204400013..204400047,-p1@RAPH1
Hg19::chr2:70188755..70188770,-p2@ASPRV1
Hg19::chr3:106617542..106617578,+p1@MTND5P16
Hg19::chr3:72387462..72387488,-p@chr3:72387462..72387488
-
Hg19::chr5:147481380..147481398,+p@chr5:147481380..147481398
+
Hg19::chr5:175837672..175837682,-p@chr5:175837672..175837682
-
Hg19::chr5:67511303..67511333,+p19@PIK3R1
Hg19::chr5:79948121..79948150,-p@chr5:79948121..79948150
-
Hg19::chr5:99385325..99385350,-p@chr5:99385325..99385350
-
Hg19::chr6:24955923..24955927,-p@chr6:24955923..24955927
-
Hg19::chr6:25004678..25004688,-p@chr6:25004678..25004688
-
Hg19::chr6:7578742..7578757,+p@chr6:7578742..7578757
+
Hg19::chr7:7604061..7604072,-p@chr7:7604061..7604072
-
Hg19::chr8:145118330..145118353,-p@chr8:145118330..145118353
-
Hg19::chr8:145118355..145118372,-p@chr8:145118355..145118372
-
Hg19::chr9:115209821..115209831,+p@chr9:115209821..115209831
+
Hg19::chr9:87879610..87879618,+p@chr9:87879610..87879618
+
Hg19::chr9:96698887..96698909,+p@chr9:96698887..96698909
+
Hg19::chrX:114608236..114608237,+p@chrX:114608236..114608237
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0008544epidermis development7.04856330701466e-07
GO:0007398ectoderm development7.04856330701466e-07
GO:0009888tissue development1.85687015891158e-05
GO:0031424keratinization4.38422775379148e-05
GO:0009913epidermal cell differentiation7.63587513186168e-05
GO:0048730epidermis morphogenesis9.04537395326773e-05
GO:0048729tissue morphogenesis0.000175394644674861
GO:0048513organ development0.000260134436990178
GO:0048731system development0.00159417645728387
GO:0005882intermediate filament0.00386161842764485
GO:0045111intermediate filament cytoskeleton0.00386161842764485
GO:0048856anatomical structure development0.00409978112833119
GO:0007275multicellular organismal development0.00796701061421971
GO:0035030phosphoinositide 3-kinase complex, class IA0.008242081714353
GO:0001867complement activation, lectin pathway0.0144204585980542
GO:0043559insulin binding0.0144204585980542
GO:0009653anatomical structure morphogenesis0.017490948924798
GO:0043125ErbB-3 class receptor binding0.025625053188339
GO:0043560insulin receptor substrate binding0.0303387592429232
GO:0032502developmental process0.037338278254163
GO:0048009insulin-like growth factor receptor signaling pathway0.0383951793796147
GO:0005856cytoskeleton0.0383951793796147
GO:0042730fibrinolysis0.0383951793796147
GO:0017046peptide hormone binding0.0383951793796147
GO:0017089glycolipid transporter activity0.0383951793796147
GO:0051861glycolipid binding0.0383951793796147
GO:0035014phosphoinositide 3-kinase regulator activity0.0383951793796147
GO:0046836glycolipid transport0.0397103858141704
GO:0030280structural constituent of epidermis0.0397103858141704
GO:0005159insulin-like growth factor receptor binding0.042216059074444
GO:0030195negative regulation of blood coagulation0.0445584391949209
GO:0032501multicellular organismal process0.0453360829683806
GO:0030193regulation of blood coagulation0.0453360829683806



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.